Preoperative Stent Study

Sponsor
Karolinska Institutet (Other)
Overall Status
Completed
CT.gov ID
NCT00501176
Collaborator
(none)
92
1
2
96
1

Study Details

Study Description

Brief Summary

Randomized study comparing the effect of plastic stents to that of expandable metal stents as pre-operative drainage of the bile ducts prior to Whipple operation.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Plastic and metalic stent inserion
N/A

Detailed Description

Patients suffering from a locally invasive tumour process in the Periampullary area usually seek medical attention because of jaundice. Not only do patients suffering from jaundice show significant symptoms of exhaustion and purities, but they are also at higher risk for developing post-operative complications. Experimentally, the liver exhibits a reduced capacity for tolerating ischemia in the presence of jaundice. Several different etiologic factors suggest cause complication such as presence of toxic substances as bilirubin and bile salts, impaired nutritional status, effects of endotoxins, bacterial translocation, modulation of the inflammatory cascade with cytokine release, reduction of cellular immunity and nutritional. These complications primarily consist of septic complications (cholangitis, abscesses, and leakage), haemorrhage, impaired wound healing and renal disorders. Summarily, these issues have motivated pre-operative bile flow drainage by way of stent. Traditionally, pre-operative bile flow drainage has been achieved by insertion of a EP because these are considered easy to remove and cause less tissue reaction in the bile ducts. However, multiple studies have found the disadvantage with the EP is that it provides poorer bile drainage than the SEMS.

In palliative situations, metal stents have been associated with fewer side-effects in the form of fever relapse of jaundice, etc. These effects are likely due to better bile flow through the stent. It remains unclear if metal stents can provide similar advantages in the curative situation.

Study Design

Study Type:
Interventional
Actual Enrollment :
92 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Randomized Study Comparing the Effect of Plastic Stents to That of Expandable Metal Stents Prior to Pancreaticoduodenectomy
Study Start Date :
Dec 1, 2006
Actual Primary Completion Date :
Nov 1, 2014
Actual Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: plastic stent

Stent insertion

Procedure: Plastic and metalic stent inserion
Patient randomizes to metal or plastic insertion prior to Whipple procedure
Other Names:
  • Two types of Stent prior to Whipple procedure
  • Active Comparator: metalic stent

    Stent inserttion

    Procedure: Plastic and metalic stent inserion
    Patient randomizes to metal or plastic insertion prior to Whipple procedure
    Other Names:
  • Two types of Stent prior to Whipple procedure
  • Outcome Measures

    Primary Outcome Measures

    1. Intra-operative measurement of the Culture from the bile. [Intraoperativt]

    Secondary Outcome Measures

    1. Intraoperative measurements of inflammatory reaction in the liver, hepatoduodenal ligament and around the bile ducts with biopsies. Stent dysfunction and cholangitis after ERCP and pre-operative bile flow relief. Postoperative analysis. [Perioperative]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • The primary inclusion criteria are all patients with operable Periampullary cancer and jaundice who have not previously undergone bile flow drainage.
    Exclusion Criteria:
    • Define as failed ERCP, patients who have previously undergone bile flow drainage or radical surgery is not possible.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Karolinksa University Hospital Stockholm Sweden 14186

    Sponsors and Collaborators

    • Karolinska Institutet

    Investigators

    • Principal Investigator: Lars Enochsson, MD, PhD, Karolinksa Institutet
    • Study Director: Urban Arnelo, M.D., Karolinska Institutet
    • Study Chair: Lars Lundell, Professor, Karolinska Institutet

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Karolinska Institutet
    ClinicalTrials.gov Identifier:
    NCT00501176
    Other Study ID Numbers:
    • ยจ2006/220-31/4
    First Posted:
    Jul 13, 2007
    Last Update Posted:
    Jun 29, 2022
    Last Verified:
    Jun 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Karolinska Institutet
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 29, 2022